NCT06024291View on ClinicalTrials.gov

Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Trial

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

January 15, 2025

Study Completion Date

January 15, 2025

Conditions
Overweight and ObesityDyslipidemiasBlood PressureCardiovascular DiseasesMetabolic Disease
Interventions
OTHER

8-week HIIT programme

See arm description

OTHER

Physical activity recommendation

See arm description

Trial Locations (1)

4052

Department of Sport, Exercise and Health, University of Basel, Basel

All Listed Sponsors
collaborator

University of Lausanne

OTHER

collaborator

Technical University of Munich

OTHER

lead

University of Basel

OTHER

NCT06024291 - Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Trial | Biotech Hunter | Biotech Hunter